Presence of an endogenous inhibitor of dipeptidyl carboxypeptidase in rat brain |
| |
Authors: | Paul A. Velletri Walter Lovenberg |
| |
Affiliation: | Section on Biochemical Pharmacology, Hypertension-Endocrine Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland 20205, U.S.A. |
| |
Abstract: | Whole rat brain dipeptidyl carboxypeptidase (E.C. 3.4.15.1) was heterogeneously distributed among 10 brain regions studied. In corpus striatum, the enzyme was enriched in the P2 pellet, a subfraction high in myelin and nerve terminals. Using [3H]benzoylphenylalanyl-alanyl-proline as a substrate, dipeptidyl carboxypeptidase manifested a different anion requirement than has been reported for other substrates. Endogenous inhibitors of the enzyme were found in corpus striatum and could be removed by dialysis or Sephadex G25 chromatography. Boiled striatal cytosol inhibited membrane-bound enzyme activity in a concentration-dependent manner and confirmed the presence of an endogenous soluble, heat-stable inhibitor in rat brain. The inhibitor apparently could be degraded by a component of the striatal P2 membranes. The inhibitor was present in all 10 brain regions studied and its levels did not appear to be related to the specific activity of dipeptidyl carboxypeptidase. Potential mechanisms for biological regulation of dipeptidyl carboxypeptidase activity are discussed in light of the above findings. |
| |
Keywords: | Address for correspondence: Section on Biochemical Pharmacology National Heart Lung and Blood Institute Bldg 10 Rm 7N262 National Institutes of Health Bethesda Maryland 20205 U.S.A. |
本文献已被 ScienceDirect 等数据库收录! |
|